In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

When certified dog trainer Nanette Lai had an MS flare, she figured out workarounds to allow her to still take care of her ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

Founded in 1946, the National Multiple Sclerosis Society funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their ...

A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

Denise Mihell decided to move to the Glen Elm Mobile Home Community in 2015 to be near her mother and help care for her ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although Merck is providing it to the NHS in England at a confidential discount. The new guidance is due to be finalised in April, with ...